DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A ISOFORMS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A ISOFORMS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Published:2015-04 Issue:4 Volume:35 Page:764-772
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Grisanti Swaantje,Zhu Qi,Tatar Olcay,Lueke Julia,Lueke Matthias,Tura Aysegul,Grisanti Salvatore

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference38 articles.

1. . Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.;Klein;Ophthalmology,2007

2. Vascular endothelial growth factor: basic science and clinical progress.;Ferrara;Endocr Rev,2004

3. . Vascular endothelial growth factor and angiogenesis.;Hoeben;Pharmacol Rev,2004

4. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.;Das;Prog Retin Eye Res,2003

5. . Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.;Tatar;Am J Ophthalmol,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical effects and mechanism of action of ranibizumab in treating myopic choroidal neovascularization;2024-04-26

2. Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study;Ophthalmology and Therapy;2024-03-26

3. Does ranibizumab biosimilars fare as well in macular neovascularisation?;Indian Journal of Clinical and Experimental Ophthalmology;2024-03-15

4. Curcumin and Wnt/β‑catenin signaling in exudative age‑related macular degeneration (Review);International Journal of Molecular Medicine;2022-04-19

5. Treatment Landscape of Macular Disorders in Indian Patients with the Advent of Razumab™ (World’s First Biosimilar Ranibizumab): A Comprehensive Review;Ophthalmology and Therapy;2021-06-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3